Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival

Journal of Clinical Oncology

Volumn 24, Issue 27, 2006, Pages 4464-4471

  Cascinelli, Natale ^a   Bombardieri, Emilio ^a   Bufalino, Rosaria ^a   Camerini, Tiziana ^a   Carbone, Antonino ^a   Clemente, Claudio ^a   Lenisa, Leonardo ^a   Mascheroni, Luigi ^a   Maurichi, Andrea ^a   Pennacchioli, Elisabetta ^a   Patuzzo, Roberto ^a   Santinami, Mario ^a   Tragni, Gabrina ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY TECHNIQUE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; FACTUAL DATABASE; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; STATISTICAL MODEL; SURVIVAL;

ADULT; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33749054227     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.3198     Document Type: Article

References (26)

1. Medalie N, Ackerman AB: Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Br J Dermatol 151:298-307, 2004
2. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
3. Morton DL, Thompson JF, Essner R, et al: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Ann Surg 230:453-465, 1999
4. Thompson JF, Uren RF, Shaw HM, et al: The location of the sentinel lymph node in cutaneous melanoma: New insights into lymphatic anatomy. J Am Coll Surg 189:195-206, 1999
5. Cochran AJ, Baildar BR, Starz H, et al: The Augsburg Consensus: Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 89:236-241, 2000
6. Karimipour DJ, Lowe L, Su L, et al: Standard immunostains for melanoma in sentinel lymph node specimens: Which ones are most useful? J Am Acad Dermatol 50:759-764, 2004
7. Starz H: Pathology of the sentinel lymph node in melanoma. Semin Oncol 31:357-362, 2004
8. Dewar DJ, Newell B, Green MA, et al: The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22:3345-3349, 2004
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
10. Mantel H, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
11. Cox DR: Regression models and life tables (with discussion). J Royal Stat Soc 34:187-220, 1972 (Series B)
12. McCarthy WH, Shaw HM, Thompson JF, et al: Time and frequency of recurrence of cutaneous stage I malignant melanoma: Guidelines for followup. Surg Gynecol Obstet 166:497-502, 1988
13. Clary BM, Brady MS, Lewis JL, et al: Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233:250-258, 2001
14. Soong SJ, Shaw HM, Balch CM, et al: Predicting survival and recurrence in localized melanoma: A multivariate approach. World J Surg 16:191-195, 1992
15. Cascinelli N, Marubini E, Morabito A, et al: Prognostic factors for stage I melanoma of the skin: A review. Stat Med 4:265-278, 1985
16. Averbook BJ, Russo LJ, Mansour EG: A long-term analysis of 620 patients with malignant melanoma at a major referral center. Surgery 124:746-756, 1998
17. Buzaid AC, Ross MI, Balch CM, et al: Critical analysis of the current American Joint Committee on Cancer Staging System for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 15:1039-1051, 1997
18. Reeves ME, Delgado R, Busam KJ, et al: Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 10:27-31, 2003
19. Cochran AJ, Wen DR, Huang RR, et al: Prediction of metastatic melanoma in nonsentinel nodes and clinical outcomes based on the primary melanoma and the sentinel node. Mod Pathol 17: 747-755, 2004
20. Starz H, Siedlecki K, Balda BR: Sentinel lymphonodenectomy and S-classification: A successful strategy for better prediction and improvement of outcome in melanoma. Ann Surg Oncol 11:162S-168S, 2004 (suppl)
21. Scolyer RA, Li LL, McCarthy SW, et al: Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 122:532-539, 2004
22. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 19:3622-3634, 2001
23. Starz H, Balda BR, Kramer KU, et al: A micromorphometry based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 91:2110-2121, 2001
24. Wagner JD, Gordon MS, Chuang TY, et al: Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 89:453-462, 2000
25. McMaster KM, Wong SL, Edwards MJ, et al: Frequency of nonsentinel lymph node metastases in melanoma. Ann Surg Oncol 9:137-141, 2002
26. Fink AM, Weihsengruber F, Spangl B, et al: S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection. Melanoma Res 15:267-271, 2005